Andrew Frisella
CEO
1st Phorm LLC
2091 Fenton Logistics Park Blvd
Fenton , MO 63026
United StatesFEI 3011673789Issued Jul 29, 2021Office of Human and Animal Food West Division II
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3011673789.
Violations2
Issue DateJul 29, 2021
Product TypeDrugs
StatusClosed
Closeout LetterFeb 15, 2022
Letter Details
Firm
1st Phorm LLC
Location
Andrew Frisella
CEO
1st Phorm LLC
2091 Fenton Logistics Park Blvd
Fenton , MO 63026
United States
FEI Number
3011673789
Country
United States
Issue Date
July 29, 2021
Issuing Office
Office of Human and Animal Food West Division II
Product Type
Drugs
Status
Closed
Closeout Letter
February 15, 2022
Summary
1st Phorm LLC was cited for marketing unapproved new drugs and misbranded products, specifically Whole Heart Cardiovascular Health Formula and Full-Mega Omega-3 Fish Oil, based on disease claims made on their website. The company violated the Federal Food, Drug, and Cosmetic Act by making statements indicating these products were intended to cure, mitigate, treat, or prevent diseases such as cardiovascular disease, heart attacks, high blood pressure, arthritis, and acne—claims that established the products as drugs requiring FDA approval. Specific violations included therapeutic statements such as "designed to combat cardiovascular disease and heart attacks" and claims that the products could "help decrease unhealthy levels of LDL cholesterol" and "lower inflammation," which the FDA determined lacked the required new drug applications.